Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 16481630)

1.

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ; European Crohn's and Colitis Organisation.

Gut. 2006 Mar;55 Suppl 1:i36-58.

2.

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Travis SP, Stange EF, Lémann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ; European Crohn's and Colitis Organisation.

Gut. 2006 Mar;55 Suppl 1:i16-35.

3.

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, Dotan I, Marteau P, Ardizzone A, Baumgart DC, D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G, Reinshagen M, Tsianos E, Herrlinger K, Oldenburg B, Bouhnik Y, Kiesslich R, Stange E, Travis S, Lindsay J; European Crohn's and Colitis Organisation (ECCO).

J Crohns Colitis. 2010 Feb;4(1):63-101. doi: 10.1016/j.crohns.2009.09.009. Epub 2009 Dec 21. No abstract available.

5.

Maintenance of remission in Crohn's disease: current and emerging therapeutic options.

Brookes MJ, Green JR.

Drugs. 2004;64(10):1069-89. Review.

PMID:
15139787
6.

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.

Dig Liver Dis. 2005 Jun;37(6):407-17. Review.

PMID:
15893279
7.

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.

Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P, Genser D, Petritsch W, Raithel M, Hoffmann R, Gross V, Plauth M, Staun M, Nesje LB.

Gastroenterology. 2000 Feb;118(2):264-73. Erratum in: Gastroenterology 2000 Jul;119(1):280.

PMID:
10648454
8.

Prevention of postoperative recurrence in Crohn's disease.

Terdiman JP.

Clin Gastroenterol Hepatol. 2008 Jun;6(6):616-20. Epub 2007 Oct 29. No abstract available.

PMID:
17967564
9.

Management of inflammatory bowel disease.

Botoman VA, Bonner GF, Botoman DA.

Am Fam Physician. 1998 Jan 1;57(1):57-68, 71-2. Review.

10.

Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.

Bauer WM, Brzezinski A, Lashner BA.

Curr Gastroenterol Rep. 1999 Oct;1(5):377-83. Review.

PMID:
10980975
11.

[Postoperative recurrence in Crohn's disease].

Caprilli R, Taddei G, Viscido A.

Chir Ital. 1995;47(5):25-32. Review. Italian.

PMID:
9162601
12.

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

Bourreille A, Ignjatovic A, Aabakken L, Loftus EV Jr, Eliakim R, Pennazio M, Bouhnik Y, Seidman E, Keuchel M, Albert JG, Ardizzone S, Bar-Meir S, Bisschops R, Despott EJ, Fortun PF, Heuschkel R, Kammermeier J, Leighton JA, Mantzaris GJ, Moussata D, Lo S, Paulsen V, Panés J, Radford-Smith G, Reinisch W, Rondonotti E, Sanders DS, Swoger JM, Yamamoto H, Travis S, Colombel JF, Van Gossum A; World Organisation of Digestive Endoscopy (OMED) and the European Crohn's and Colitis Organisation (ECCO).

Endoscopy. 2009 Jul;41(7):618-37. doi: 10.1055/s-0029-1214790. Epub 2009 Jul 8. Review.

PMID:
19588292
13.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
14.

Review article: medical treatment of active Crohn's disease.

Scribano ML, Prantera C.

Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:35-9. Review.

PMID:
12047258
15.

Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.

Cottone M, Orlando A, Viscido A, Calabrese E, Cammà C, Casà A.

Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:38-42. Review.

PMID:
12786611
16.

[Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases].

Rath HC, Andus T, Caesar I, Schölmerich J.

Med Klin (Munich). 1998 Jul 15;93(7):395-400. German.

PMID:
9711052
17.

[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].

Karoui S, Kallel L, Boubaker J, Filali A.

Tunis Med. 2006 Oct;84(10):595-8. Review. French.

PMID:
17193847
18.

Pregnancy and Crohn's disease.

Mottet C, Juillerat P, Gonvers JJ, Froehlich F, Burnand B, Vader JP, Michetti P, Felley C.

Digestion. 2005;71(1):54-61. Epub 2005 Feb 4. Review.

PMID:
15711051
19.

Crohn's disease over 20 years after diagnosis in a referral population.

Etienney I, Bouhnik Y, Gendre JP, Lémann M, Cosnes J, Matuchansky C, Beaugerie L, Modigliani R, Rambaud JC.

Gastroenterol Clin Biol. 2004 Dec;28(12):1233-9.

20.

Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease.

Steinhart AH, Forbes A, Mills EC, Rodgers-Gray BS, Travis SP.

Aliment Pharmacol Ther. 2007 Jun 15;25(12):1389-99. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk